Showing 621-630 of 6934 results for "".
EBDs, CBD, Millennials, and More in the Mix at CSF
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/ebds-cbd-millennials-and-more-in-the-mix-at-csf/23131/Get the scoop on what will happen live at CSF 2019!Inside the Minds of Acne Patients
https://practicaldermatology.com/columns/clinical-focus-1/inside-the-minds-of-acne-patients/23634/Recommendations on how to start developing a treatment plan with its roots in the psychology of the acne patient.Do Lasers Work for Acne?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/do-lasers-work-for-acne/20999/Lasers represent an attractive option for acne patients who have not responded to traditional therapies and who either cannot or will not take oral medications.The Future of Interleukin-based Therapy
https://practicaldermatology.com/topics/practice-management/the-future-of-interleukin-based-therapy/21133/IL inhibitors offer the promise of increased efficacy. Here is a snapshot view of current and investigational agents.An Update on the Use of Minocycline for the Treatment of Acne
https://practicaldermatology.com/columns/clinical-focus-1/an-update-on-the-use-of-minocycline-for-the-treatment-of-acne/23201/Advances in formulation technology have led to the development of a stable topical minocycline that recently received FDA approval. Here’s what you should know.Physician Spotlight: Roy Geronemus, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-roy-geronemus-md/23151/PRP: What Dermatologists Should Know
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/prp-what-dermatologists-should-know/20333/Long used in orthopedic medicine and made popular on social media, PRP has science to support its use in dermatology.What Does Efficacy Cost? Evidence for Relative Cost-Effectiveness of Biologic Therapies for Psoriasis
https://practicaldermatology.com/topics/psoriasis/what-does-efficacy-cost-evidence-for-relative-cost-effectiveness-of-biologic-therapies-for-psoriasis/23128/Despite high costs, evidence suggests that biologics are cost-effective options for moderate to severe psoriasis because of their efficacy.Prurigo Nodularis: An Update for Clinicians, Part 2
https://practicaldermatology.com/topics/atopic-dermatitis/prurigo-nodularis-an-update-for-clinicians-part-2/20490/Here's a look at the management of this condition, which is commonly associated with atopic dermatitis.The Microbiome: What Do We Know Now?
https://practicaldermatology.com/topics/atopic-dermatitis/the-microbiome-what-do-we-know-now/23122/Questions and answers about the microbiome and its role in influencing cutaneous health.